These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. New drug therapies for glaucoma. Bartlett JD J Am Optom Assoc; 1996 Nov; 67(11):648-53. PubMed ID: 8979656 [No Abstract] [Full Text] [Related]
26. Pharmacological therapy for glaucoma: a review. Hoyng PF; van Beek LM Drugs; 2000 Mar; 59(3):411-34. PubMed ID: 10776828 [TBL] [Abstract][Full Text] [Related]
27. The impact of common classes of topical antiglaucoma medications on central corneal thickness--own observations. Wierzbowska J; Łagocka A; Siemiatkowska A; Robaszkiewicz J; Stankiewicz A; Sierdziński J Klin Oczna; 2009; 111(10-12):323-6. PubMed ID: 20169887 [TBL] [Abstract][Full Text] [Related]
28. New developments in the drug treatment of glaucoma. Hurvitz LM; Kaufman PL; Robin AL; Weinreb RN; Crawford K; Shaw B Drugs; 1991 Apr; 41(4):514-32. PubMed ID: 1711957 [TBL] [Abstract][Full Text] [Related]
29. [Pleiotropic effects in local drug treatment for glaucoma]. Erb C Klin Monbl Augenheilkd; 2013 Feb; 230(2):141-5. PubMed ID: 23430678 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the long-term effects of various topical antiglaucoma medications on meibomian glands. Arita R; Itoh K; Maeda S; Maeda K; Furuta A; Tomidokoro A; Aihara M; Amano S Cornea; 2012 Nov; 31(11):1229-34. PubMed ID: 22406943 [TBL] [Abstract][Full Text] [Related]
31. Management of glaucoma: focus on pharmacological therapy. Marquis RE; Whitson JT Drugs Aging; 2005; 22(1):1-21. PubMed ID: 15663346 [TBL] [Abstract][Full Text] [Related]
32. Controversies in Glaucoma: Current Medical Treatment and Drug Development. Bucolo C; Platania CB; Reibaldi M; Bonfiglio V; Longo A; Salomone S; Drago F Curr Pharm Des; 2015; 21(32):4673-81. PubMed ID: 26350532 [TBL] [Abstract][Full Text] [Related]
33. Glaucoma medication during pregnancy and nursing. Coppens G; Stalmans I; Zeyen T Bull Soc Belge Ophtalmol; 2010; (314):33-6. PubMed ID: 20480749 [TBL] [Abstract][Full Text] [Related]
34. [Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost]. Hoyng PF; Rasker MT Ned Tijdschr Geneeskd; 1998 Sep; 142(39):2138-41. PubMed ID: 9856229 [TBL] [Abstract][Full Text] [Related]
35. Glaucoma pharmacotherapy: implications for flying fitness. Lam PM Aviat Space Environ Med; 2005 Aug; 76(8):786-93. PubMed ID: 16110697 [TBL] [Abstract][Full Text] [Related]
36. [Trusopt--a new form of drug for treating glaucoma]. Izdebska J Klin Oczna; 1997; 99(3):217-20. PubMed ID: 9456571 [TBL] [Abstract][Full Text] [Related]
37. Costs and persistence of carbonic anhydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK-GPRD database. Lafuma A; Berdeaux G Curr Med Res Opin; 2008 May; 24(5):1519-27. PubMed ID: 18413015 [TBL] [Abstract][Full Text] [Related]
38. Pharmacologic management of glaucoma. Samples JR Ration Drug Ther; 1987 Dec; 21(12):1-6. PubMed ID: 2896368 [No Abstract] [Full Text] [Related]
39. Glaucoma medical treatment: philosophy, principles and practice. Migdal C Eye (Lond); 2000 Jun; 14 ( Pt 3B)():515-8. PubMed ID: 11026981 [TBL] [Abstract][Full Text] [Related]